Sagimet Biosciences Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 6.63 million compared to USD 6.59 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.17 USD | +7.26% | +7.26% | -4.61% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.61% | 170M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- SGMT Stock
- News Sagimet Biosciences Inc.
- Sagimet Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024